5-lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death
- 1 November 1998
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 37 (3) , 161-173
- https://doi.org/10.1002/(sici)1097-0045(19981101)37:3<161::aid-pros5>3.0.co;2-d
Abstract
BACKGROUND Products of the arachidonic acid-metabolizing enzyme, 5-lipoxygenase, stimulate the growth of several cell types. Selective inhibitors of the enzyme, including SC41661A and MK886, reduce PC-3 prostate cell proliferation. With continued culture, cells die, but the mode of death, necrotic or nonnecrotic, has not been established. METHODS Flow cytometry, laddering after agarose electrophoresis of DNA from inhibitor-treated cells, and light and electron microscopy were employed to examine the type of death in PC-3 prostate cells cultured with either 5-lipoxygenase inhibitor. RESULTS The inhibitors induced nonnecrotic, programmed cell death. SC41661A-treated cells exhibited “foamy,” vacuolated cytoplasm and mitochondria with disrupted cristae and limiting membranes, while some cells contained numerous polysomes and extended hypertrophic Golgi and secretory cisternal networks. A proportion of the treated cells detached and the nuclei of these cells were characteristic of type 1 “apoptotic” programmed cell death. MK886, a 5-lipoxygenase- inhibitor with a different mechanism of action, induced nonnecrotic changes largely confined to the cytoplasm, most consistent with type 2 “autophagic” programmed cell death. In preliminary studies of mechanism, we demonstrated that PC-3 cells express mRNA for 5-lipoxygenase and for 5-lipoxygenase-activating protein. The less active inhibitor, SC45662 neither reduced proliferation nor induced DNA laddering. The antioxidant, N-acetyl-l-cysteine but not butylated hydroxy toluene or alpha tocopherol, partially reduced the inhibition of proliferation from SC41661A. CONCLUSIONS SC41661A and MK886 inhibit PC-3 cell proliferation and induce a form of type 1 or type 2 programmed cell death, respectively. PC-3 cells contain messenger RNA for 5-lipoxygenase and 5-lipoxygenase-activating proteins. Drug-induced changes included altered redox potential, inferred from the increased survival due to the antioxidant and glutathione precursor, N-acetyl.-l-cysteine. PC-3 cells are an appropriate model for studying the mechanism responsible for 5-lipoxygenase inhibitor-induced cellular suicide. Prostate 37:161–173, 1998.Keywords
This publication has 24 references indexed in Scilit:
- Oxidative stress as a mediator of apoptosisPublished by Elsevier ,2002
- Arachidonic Acid Stimulates Prostate Cancer Cell Growth: Critical Role of 5-LipoxygenaseBiochemical and Biophysical Research Communications, 1997
- Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria BlockedScience, 1997
- The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of ApoptosisScience, 1997
- Mitochondrial control of apoptosisPublished by Elsevier ,1997
- Cells en route to apoptosis are characterized by the upregulation of c‐fos, c‐myc, c‐jun, cdc2, and RB phosphorylation, resembling events of early cell‐cycle traverseJournal of Cellular Biochemistry, 1995
- Evaluation of Cell Death in EB V-Transformed Lymphocytes Using Agarose Gel Electrophoresis, Light Microscopy and Electron Microscopy: II. Induction of Non-Classic Apoptosis (“Para-Apoptosis”) by Tritiated ThymidineLeukemia & Lymphoma, 1995
- Bcl-2 functions in an antioxidant pathway to prevent apoptosisCell, 1993
- 5‐lipoxygenase‐activating protein is an arachidonate binding proteinFEBS Letters, 1993
- Human PC‐3 prostate cell line DNA synthesis is suppressed by eicosatetraynoic acid, an in vitro inhibitor of arachidonic acid metabolismThe Prostate, 1988